TREATMENT AND PREVENTION OF UROLITHIASIS IN PATIENTS WITH STONES OF VARIOUS LOCATIONS

А.А. Камалов; В.К. Карпов; А.Н. Низов; Д.А. Охоботов; И.Н. Ответчиков; А.А. Притыко; Е.С. Тимохи

TREATMENT AND PREVENTION OF UROLITHIASIS IN PATIENTS WITH STONES OF VARIOUS LOCATIONS

А.А. Камалов¹, В.К. Карпов², А.Н. Низов³, Д.А. Охоботов⁴, И.Н. Ответчиков⁵, А.А. Притыко⁶, Е.С. Тимохи⁷

research article UDC 616.61 Pages: 4-9

Keywords: recurrent urolithiasis nephrolitholapaxia ureteroscopy urolithiasis markers urolithiasis and infravesical obstruction

Abstract

To find the most optimal approach to the treatment of patients with urolithiasis

and establish the need of disease monitoring to further select the

means of the recurrent urolithiasis prevention.

How to cite

Камалов А.А., Карпов В.К., Низов А.Н., Охоботов Д.А., Ответчиков И.Н., Притыко А.А., Тимохи Е.С. ЛЕЧЕНИЕ И ПРОФИЛАКТИКА МОЧЕКАМЕННОЙ БОЛЕЗНИ У ПАЦИЕНТОВ С КАМНЯМИ РАЗЛИЧНОЙ ЛОКАЛИЗАЦИИ // Технологии живых систем. 2018. № 1. С. 4–9.

References

Khan S.R., Rodriguez D.E., Gower L.B., Monga M. Association of Randall's Plaques with Collagen Fibers and Membrane Vesicles // Journal of Urology. 2012. V. 187. № 3. Р. 1094–1100.
Letavernier E., Vandermeersch S., Traxer O., Tligui M., Baud L., Ronco P., Haymann J.-Ph., Daudon M. Demographics and Characterization of 10,282 Randall Plaque-Related Kidney Stones. A New Epidemic? // Medicine (Baltimore). 2015. V. 94. № 10. Р. 566.
Khan S.R., Canales B.K. Unified theory on the pathogenesis of Randall's plaques and plugs // Urolithiasis. 2015. V. 43. № 1. Р. 109−123.
Lulich J.P., Osborne C.A., Carvalho M., Nakagawa Y. Effects of a urolith prevention diet on urine compositions of glycosaminoglycans, TammHorsfall glycoprotein, and nephrocalcin in cats with calcium oxalate urolithiasis // Am. J. Vet. Res. 2012. V. 73. № 3. Р. 447−451.
Daudon M., Frochot V. Crystalluria // Clinical Chemistry and Laboratory Medicine (CCLM). November 2015. V. 53. № 2. P. 1479–1487.
Arrabal-Martín M., González-Torres S. Treatment with hydrochlorothiazide and alendronate in patients with stones and bone mineral density loss. Evolution of bone metabolism and calciuria with medical treatment //Arch. Esp. Urol. 2016. V. 69. № 1. Р. 9−18.
Tsuji H., Shimizu N., Nozawa M., Umekawa T., Yoshimura K., De Velasco M.A., Uemura H., Khan S.R. Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition // Urolithiasis. 2014. V. 42. № 3. Р.195−202.

[1] Khan S.R., Rodriguez D.E., Gower L.B., Monga M. Association of Randall's Plaques with Collagen Fibers and Membrane Vesicles // Journal of Urology. 2012. V. 187. № 3. Р. 1094–1100.

[2] Letavernier E., Vandermeersch S., Traxer O., Tligui M., Baud L., Ronco P., Haymann J.-Ph., Daudon M. Demographics and Characterization of 10,282 Randall Plaque-Related Kidney Stones. A New Epidemic? // Medicine (Baltimore). 2015. V. 94. № 10. Р. 566.

[3] Khan S.R., Canales B.K. Unified theory on the pathogenesis of Randall's plaques and plugs // Urolithiasis. 2015. V. 43. № 1. Р. 109−123.

[4] Lulich J.P., Osborne C.A., Carvalho M., Nakagawa Y. Effects of a urolith prevention diet on urine compositions of glycosaminoglycans, TammHorsfall glycoprotein, and nephrocalcin in cats with calcium oxalate urolithiasis // Am. J. Vet. Res. 2012. V. 73. № 3. Р. 447−451.

[5] Daudon M., Frochot V. Crystalluria // Clinical Chemistry and Laboratory Medicine (CCLM). November 2015. V. 53. № 2. P. 1479–1487.

[6] Arrabal-Martín M., González-Torres S. Treatment with hydrochlorothiazide and alendronate in patients with stones and bone mineral density loss. Evolution of bone metabolism and calciuria with medical treatment //Arch. Esp. Urol. 2016. V. 69. № 1. Р. 9−18.

[7] Tsuji H., Shimizu N., Nozawa M., Umekawa T., Yoshimura K., De Velasco M.A., Uemura H., Khan S.R. Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition // Urolithiasis. 2014. V. 42. № 3. Р.195−202.